毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688073 毕得医药

已收盘 09-05 15:00:00

{"stockData":{"symbol":"688073","market":"SH","secType":"STK","nameCN":"毕得医药","latestPrice":65,"timestamp":1757055600000,"preClose":62.65,"halted":0,"volume":1819057,"delay":0,"changeRate":0.0375,"floatShares":43234200,"shares":90882900,"eps":1.5294,"marketStatus":"已收盘","change":2.35,"latestTime":"09-05 15:00:00","open":62.11,"high":65.44,"low":61.88,"amount":117000000,"amplitude":0.0568,"askPrice":65,"askSize":11,"bidPrice":64.81,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.5294,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1757295000000},"marketStatusCode":5,"adr":0,"adjPreClose":62.65,"symbolType":"stock_kcb","openAndCloseTimeList":[[1757035800000,1757043000000],[1757048400000,1757055600000]],"highLimit":68.92,"lowLimit":56.39,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":90882948,"isCdr":false,"pbRate":3.03,"roa":"--","peRate":42.500327,"roe":"3.6%","epsLYR":1.32,"committee":0.125,"marketValue":5907000000,"turnoverRate":0.0421,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-09-08。","afterMarket":{"amount":0,"volume":0,"close":65,"buyVolume":0,"sellVolume":0,"time":1757057639260,"indexStatus":"已收盘 09-05 15:30:00","preClose":62.65},"floatMarketCap":2810000000},"requestUrl":"/m/hq/s/688073","defaultTab":"news","newsList":[{"id":"2565551021","title":"毕得医药(688073.SH)股东舟山欣曦、宁波兰旦及其一致行动人拟减持不超2.86%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2565551021","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565551021?lang=zh_cn&edition=full","pubTime":"2025-09-05 18:27","pubTimestamp":1757068079,"startTime":"0","endTime":"0","summary":"智通财经APP讯，毕得医药(688073.SH)公告，公司股东舟山欣曦、宁波兰旦及其一致行动人吴波先生计划减持其所持有的公司股份。其中，舟山欣曦拟通过大宗交易方式减持公司股份数量不超过90.88万股，即不超过公司总股本的1.00%;宁波兰旦拟通过大宗交易方式减持公司股份数量不超过90.88万股，即不超过公司总股本的1.00%;股东吴波拟通过集中竞价交易方式减持公司股份数量不超过78.58万股，即不超过公司总股本的0.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2565455192","title":"毕得医药：舟山欣曦拟减持1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2565455192","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565455192?lang=zh_cn&edition=full","pubTime":"2025-09-05 18:14","pubTimestamp":1757067271,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2564087324","title":"9月4日毕得医药跌9.44%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564087324","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564087324?lang=zh_cn&edition=full","pubTime":"2025-09-04 16:24","pubTimestamp":1756974252,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日毕得医药跌9.44%，收盘报62.65元，换手率5.1%，成交量2.21万手，成交额1.42亿元。重仓毕得医药的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400025223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2564325680","title":"生物制品板块盘中走弱，毕得医药领跌10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564325680","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564325680?lang=zh_cn&edition=full","pubTime":"2025-09-04 14:26","pubTimestamp":1756967182,"startTime":"0","endTime":"0","summary":"9月4日，生物制品板块盘中下跌3.02%，毕得医药领跌10.32%，迈威生物-U跌超10%，甘李药业跌超8%，百利天恒、百济神州-U跌超7%。板块实时资金流向显示，今日超大单净流出9.13亿元，今日小单净流入7.71亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/04142652918309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2563838302","title":"每周股票复盘：毕得医药（688073）一周现多笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2563838302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563838302?lang=zh_cn&edition=full","pubTime":"2025-08-31 06:37","pubTimestamp":1756593430,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，毕得医药报收于67.11元，较上周的64.52元上涨4.01%。本周，毕得医药8月25日盘中最高价报68.81元。8月28日盘中最低价报58.19元。毕得医药当前最新总市值60.99亿元，在医疗服务板块市值排名31/50，在两市A股市值排名2826/5152。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100002246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2563018280","title":"毕得医药上涨7.78%，报65.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2563018280","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563018280?lang=zh_cn&edition=full","pubTime":"2025-08-29 13:05","pubTimestamp":1756443901,"startTime":"0","endTime":"0","summary":"8月29日，毕得医药盘中上涨7.78%，截至13:05，报65.5元/股，成交1.01亿元，换手率3.7%，总市值59.53亿元。截至3月31日，毕得医药股东户数3610，人均流通股1.2万股。2025年1月-3月，毕得医药实现营业收入2.96亿元，同比增长12.83%；归属净利润3069.31万元，同比增长17.71%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/29130552796611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2562594714","title":"8月27日毕得医药现858万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2562594714","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562594714?lang=zh_cn&edition=full","pubTime":"2025-08-27 17:47","pubTimestamp":1756288022,"startTime":"0","endTime":"0","summary":"近三个月该股共发生6笔大宗交易，合计成交4115.0手，折价成交6笔。该股近期无解禁股上市。截至2025年8月27日收盘，毕得医药报收于62.56元，下跌4.52%，换手率3.63%，成交量1.57万手，成交额1.01亿元。该股最近90天内共有3家机构给出评级，买入评级3家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700037969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2562781764","title":"8月26日毕得医药发生1笔大宗交易 成交金额600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562781764","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562781764?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:33","pubTimestamp":1756200815,"startTime":"0","endTime":"0","summary":"证券之星消息，8月26日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格60元，相对当日收盘价折价8.42%，成交10万股，成交金额600万元，买方营业部为海通证券股份有限公司上海宝山区牡丹江路证券营业部，卖方营业部为海通证券股份有限公司上海宝山区牡丹江路证券营业部。近三个月该股共发生5笔大宗交易，合计成交2685.0手，折价成交5笔。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600035716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2562217988","title":"8月25日毕得医药现3笔折价10.67%的大宗交易 合计成交801万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562217988","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562217988?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:31","pubTimestamp":1756114269,"startTime":"0","endTime":"0","summary":"证券之星消息，8月25日毕得医药发生大宗交易，交易数据如下：近三个月该股共发生4笔大宗交易，合计成交1685.0手，折价成交4笔。该股近期无解禁股上市。截至2025年8月25日收盘，毕得医药(688073)报收于67.17元，上涨4.11%，换手率6.1%，成交量2.64万手，成交额1.76亿元。该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为57.05。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500024187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2561042745","title":"8月22日毕得医药发生1笔大宗交易 成交金额210万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561042745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561042745?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:20","pubTimestamp":1755854447,"startTime":"0","endTime":"0","summary":"证券之星消息，8月22日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格60元，相对当日收盘价折价7.01%，成交3.5万股，成交金额210万元，买方营业部为海通证券股份有限公司上海宝山区牡丹江路证券营业部，卖方营业部为海通证券股份有限公司上海宝山区牡丹江路证券营业部。近三个月该股共发生1笔大宗交易，合计成交350.0手，折价成交1笔。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200031514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2561674444","title":"毕得医药最新公告：上半年净利润7340.61万元 同比增长41.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561674444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561674444?lang=zh_cn&edition=full","pubTime":"2025-08-21 20:11","pubTimestamp":1755778283,"startTime":"0","endTime":"0","summary":"毕得医药(688073.SH)披露2025年半年度报告，上半年实现营业收入6.28亿元，同比增长17.91%；归母净利润7340.61万元，同比增长41.6%；基本每股收益0.84元。报告期内，公司营业收入增加，同时公司进一步推进精细化管理，严格控制各项成本费用，使得业绩有较大幅度的提升。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100037216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073"],"gpt_icon":0},{"id":"2561248459","title":"毕得医药上涨6.4%，报63.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2561248459","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561248459?lang=zh_cn&edition=full","pubTime":"2025-08-21 14:45","pubTimestamp":1755758723,"startTime":"0","endTime":"0","summary":"8月21日，毕得医药盘中上涨6.4%，截至14:45，报63.88元/股，成交1.05亿元，换手率3.96%，总市值58.06亿元。公司与多个国内外顶尖的医药研发单位建立了合作伙伴关系。截至3月31日，毕得医药股东户数3610，人均流通股1.2万股。2025年1月-3月，毕得医药实现营业收入2.96亿元，同比增长12.83%；归属净利润3069.31万元，同比增长17.71%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21144552585576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2558436659","title":"毕得医药中标化学学院项目 券商看好推动股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2558436659","media":"自选股中标信息","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558436659?lang=zh_cn&edition=full","pubTime":"2025-08-11 18:12","pubTimestamp":1754907121,"startTime":"0","endTime":"0","summary":"2025年08月11日，据天眼查数据，化学学院2-[(1,3)-二氧己环-2-基]-乙基三苯基溴化瞵显示，中标方为毕得医药，招标方为化学学院。近半年内，毕得医药获得4家券商积极评价：开源证券和中邮证券给予\"买入\"评级。截至发稿，毕得医药股价报57.86元，上涨1.87%，成交额至6902.95万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811181202a481c657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811181202a481c657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2558480501","title":"毕得医药中标化学学院项目 券商积极评价彰显发展潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2558480501","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558480501?lang=zh_cn&edition=full","pubTime":"2025-08-09 18:37","pubTimestamp":1754735854,"startTime":"0","endTime":"0","summary":"2025年08月09日，据天眼查数据，化学学院2-乙酸显示，中标方为毕得医药，招标方为化学学院。近半年内，毕得医药获得4家券商积极评价：太平洋证券和开源证券给予\"买入\"评级。截至发稿，毕得医药股价报56.8元，下跌0.4%，成交额至4565.15万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809183735a47ea71d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809183735a47ea71d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2557560242","title":"上海毕得医药科技股份有限公司、安徽泽升科技股份有限公司中标采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557560242","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557560242?lang=zh_cn&edition=full","pubTime":"2025-08-08 00:36","pubTimestamp":1754584563,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月06日，药学院（深圳）发布中标结果公告，上海毕得医药科技股份有限公司和安徽泽升科技股份有限公司成为中标供应商。本次采购为线下课题组自行购买，采购金额未在数据中明确列出。采购商品包括(S)-吡咯烷-2-羧酸、苯甲酰氯及2-溴苯乙醇等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080800370994d5e80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080800370994d5e80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2557529335","title":"毕得医药中标药学院项目 券商积极评价助力业务拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2557529335","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557529335?lang=zh_cn&edition=full","pubTime":"2025-08-07 18:30","pubTimestamp":1754562641,"startTime":"0","endTime":"0","summary":"2025年08月07日，据天眼查数据，药学院5-[2,6-二-4-嘧啶基]-4--2-吡啶胺显示，中标方为毕得医药，招标方为药学院。近半年内，毕得医药获得4家券商积极评价：开源证券和太平洋证券给予\"买入\"评级。截至发稿，毕得医药股价报57.03元，下跌2.99%，成交额至8816.14万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807183045a47abeca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807183045a47abeca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2556282314","title":"毕得医药中标化学学院项目 券商积极评价提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2556282314","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556282314?lang=zh_cn&edition=full","pubTime":"2025-08-02 18:40","pubTimestamp":1754131222,"startTime":"0","endTime":"0","summary":"2025年08月02日，据天眼查数据，化学学院2,6-二溴萘显示，中标方为毕得医药，招标方为化学学院。近半年内，毕得医药获得4家券商积极评价：中邮证券和开源证券给予\"买入\"评级。截至发稿，毕得医药股价报59.3元，上涨0.85%，成交额至8224.28万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802184027a4712bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802184027a4712bf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2556231758","title":"毕得医药中标材料科学与工程学院项目 券商积极评价凸显成长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2556231758","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556231758?lang=zh_cn&edition=full","pubTime":"2025-08-02 18:40","pubTimestamp":1754131207,"startTime":"0","endTime":"0","summary":"2025年08月02日，据天眼查数据，材料科学与工程学院硼酸显示，中标方为毕得医药，招标方为材料科学与工程学院。近半年内，毕得医药获得4家券商积极评价：中邮证券和开源证券给予\"买入\"评级。截至发稿，毕得医药股价报59.3元，上涨0.85%，成交额至8224.28万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802184014a4712be7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802184014a4712be7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2556897863","title":"毕得医药中标喀斯玛商城采购订单 券商积极评价彰显发展潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2556897863","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556897863?lang=zh_cn&edition=full","pubTime":"2025-08-01 18:13","pubTimestamp":1754043181,"startTime":"0","endTime":"0","summary":"2025年08月01日，据天眼查数据，喀斯玛商城采购订单[250703315882201]公示显示，中标方为毕得医药，招标方为材料与化工学院。近半年内，毕得医药获得4家券商积极评价：太平洋证券和中邮证券给予\"买入\"评级。截至发稿，毕得医药股价报59.3元，上涨0.85%，成交额至8224.28万元。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801181304a46f8867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801181304a46f8867&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2556985282","title":"毕得医药股东大会通过变更经营范围及取消监事会等多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2556985282","media":"中访网数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556985282?lang=zh_cn&edition=full","pubTime":"2025-08-01 08:05","pubTimestamp":1754006733,"startTime":"0","endTime":"0","summary":"核心决议内容如下： 1. 变更经营范围及取消监事会 股东大会以99.9912%的高票通过了《关于变更公司经营范围、取消监事会及修改〈公司章程〉并办理工商变更登记的议案》。根据决议，公司将调整经营范围，并取消监事会架构，相关章程修订及工商变更程序将同步推进。毕得医药表示，将尽快完成工商变更及制度落地，相关进展将依规披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801081242972b6097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801081242972b6097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688073"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1757114285838,"stockEarnings":[{"period":"1week","weight":-0.0314},{"period":"1month","weight":0.1056},{"period":"3month","weight":0.4765},{"period":"6month","weight":0.2695},{"period":"1year","weight":1.2163},{"period":"ytd","weight":0.348}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":0.0491},{"period":"3month","weight":0.1262},{"period":"6month","weight":0.1305},{"period":"1year","weight":0.3673},{"period":"ytd","weight":0.1375}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海毕得医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"3782人(较上一季度增加4.76%)","perCapita":"11431股","listingDate":"2022-10-11","address":"上海市杨浦区翔殷路128号11号楼A座101室","registeredCapital":"9088万元","survey":"　　上海毕得医药科技股份有限公司的主营业务是为新药研发机构提供专业、高效的药物分子砌块及科学试剂产品及服务。公司的主要产品是分子砌块杂环化合物、分子砌块苯环化合物、分子砌块脂肪族类化合物、催化剂和配体、活性小分子化合物。","listedPrice":88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"毕得医药,688073,毕得医药股票,毕得医药股票老虎,毕得医药股票老虎国际,毕得医药行情,毕得医药股票行情,毕得医药股价,毕得医药股市,毕得医药股票价格,毕得医药股票交易,毕得医药股票购买,毕得医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}